Monthly Archives: September 2013

Featured Stories
New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

FDA Warns About Increased Death Risk With Tygacil By Pfizer

tygacil_death_risk

Tygacil (tigecycline), an antibacterial manufactured by the drug maker Pfizer, increases the risk of death, whether used for approved uses or for purposes that are off-label, according to a warning just issued by the U.S. food and Drug Administration (FDA). … Continue reading

Posted in Pharmaceuticals |

Medtronic Issued Warning Letter Over Its Diabetes Facility

medtronic_diabetes_FDA_warning

Device maker, Medtronic Inc., was just issued a warning letter from the U.S. Food and Drug Administration (FDA) concerning its Northridge, California diabetes facility. The letter was received on September 19 and discussed procedures involving “corrective and preventative action, complaint … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

Hawaii Liver Failure Cluster may be Tied to Weight Loss/Body Building Supplement

dietary_supplements_liver_failure_

The state of Hawaii is looking into a number of liver failure cases that have occurred in young, healthy adults who all took dietary or nutritional supplements. The state is issuing a public medical alert, according to KHON.com. “A cluster … Continue reading

Posted in Defective Products, DMAA Supplements, Pharmaceuticals |

Sulfonylurea Use Increases Mortality Risk in Type 2 Diabetes Treatment

sulfonylurea_increased_risks

New study results show that first-line therapy with sulfonylureas significantly increases the risk for death in patients with Type 2 diabetes compared to treatment with metformin. The combination of metformin and a sulfonylurea was also associated with a significantly increased … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Cardiac Stent Overuse Tied to Increased Deaths

cardiac_stents_overuse

The issue of cardiac stenting has highlighted potential overuse of the devices that may lead to cardiac complications. Cardiac stenting involves propping open a narrowed coronary artery with a small, metal mesh tube. During emergency surgery, for instance, when a … Continue reading

Posted in Legal News |

Baby Sunscreen Recalled Over Contamination Concerns

baby_sunscreen_recall

W.S. Badger Co. Inc. just issued a recall of all lots of its 4-ounce SPF 30 Baby Sunscreen Lotion and one lot of its 4-ounce SPF 30 Kids Sunscreen Lotion, over concerns the products have been contaminated with microbials, according … Continue reading

Posted in Defective Products, Health Concerns, Product Recalls |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors

takeda_hid_actos_risks

Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Study Finds Pradaxa Risky for Patients Implanted with Artificial Heart Valves

Pradaxa has been tied to more serious adverse reactions, according to a new study on Behringer Ingelheim’s blood thinner. The research revealed that when Pradaxa (dabigatran) is taken by patients with mechanical heart valves, there is an increase in risks … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Stryker, Medtronic Lose Preemption Bid in Lawsuit Involving Alleged Off-Label Bone Product Use

stryker_medtronic_court_lose

A preemption bid made by device makers Medtronic and Stryker to dismiss a lawsuit filed over their bone protein products has been rejected. A California state court ruled that federal law does not preempt the case from proceeding, according to … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

Heart Medicine Digoxin Leads to Higher Death Rates in Patients

digoxin_higher_death_rates

An article published online recently in the journal Circulation: Cardiovascular Quality and Outcomes found a 72 percent increase in death in heart failure patients treated with Lanoxin (digoxin) compared to those who had never taken the drug. Digoxin is used … Continue reading

Posted in Health Concerns, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.